MedTrace Logo

Using Equine Therapy in Dementia Cognitive Stimulation

NCT06662578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if integrating equine therapy in memory workshops in mild to moderate Dementias can improve cognitive function, quality of life and mood. The main question\[s\] it aims to answer is:

Does the mediation of a horse in memory workshops increase its effects ?

Researchers will compare traditional memory workshops, memory workshops using equine therapy and a control group to see if the equine therapy mediation will increase cognitive functions, mood and quality of life in individuals with mild to moderate Dementias.

Participants will participate in 8 weekly sessions of equine therapy memory workshops / traditional memory workshops / a control group will not have any interventions during that period. All subjects will be evaluated pre and post intervention period.

Conditions

Interventions

OTHER

Traditional memory workshop

The participants received 8 weekly sessions of 60 minutes of neurocognitive stimulation, based on French memory workshops.

OTHER

Equine assisted therapy memory workshops

The participants received 8 weekly sessions of 60 minutes, based on traditional memory workshops (French type of neurocognitive stimulation) with the mediation of a horse (example : working on associative memory by selecting which object is used for the horse between 2 presented objects).

Sponsors & Collaborators

  • Cooperativa de Ensino Superior, Politécnico e Universitário

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-03
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06662578 on ClinicalTrials.gov